Moreover, AML patients have reduced T helper 1 (Th1) cells and decreased IFN-γ secretion (21), while T helper 17 (Th17) cells are increased and secrete IL-17, promoting AML cell proliferation and inhibiting Th1 differentiation (16, 21). This evidence concerns the gene IFNG and acute myeloid leukemia.